Search Results - James L. Mohler

Refine Results
  1. 1
    The 2010 NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer

    The 2010 NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer by James L. Mohler

    Published 2010
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  2. 2
    NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection

    NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection by Peter Carroll, James L. Mohler

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Potential Prostate Cancer Drug Target: Bioactivation of Androstanediol by Conversion to Dihydrotestosterone

    Potential Prostate Cancer Drug Target: Bioactivation of Androstanediol by Conversion to Dihydrotestosterone by James L. Mohler, Mark Titus, Elizabeth Wilson

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents

    Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents by Danielle R. Mercatante, James L. Mohler, Ryszard Kole

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases

    The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases by Faris Azzouni, Alejandro Godoy, Yun Li, James L. Mohler

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Activated Tyrosine Kinase Ack1 Promotes Prostate Tumorigenesis: Role of Ack1 in Polyubiquitination of Tumor Suppressor Wwox

    Activated Tyrosine Kinase Ack1 Promotes Prostate Tumorigenesis: Role of Ack1 in Polyubiquitination of Tumor Suppressor Wwox by Nupam P. Mahajan, Young E. Whang, James L. Mohler, H. Shelton Earp

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)

    Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2) by Ruth M. Lunn, Douglas A. Bell, James L. Mohler, Jack A. Taylor

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer

    Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer by Mark Titus, Michael J. Schell, Fred B. Lih, Kenneth B. Tomer, James L. Mohler

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP

    Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP by Adam R. Karpf, Suxia Bai, Smitha R. James, James L. Mohler, Elizabeth M. Wilson

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Genetic polymorphism and prostate cancer aggressiveness: A case‐only study of 1,536 GWAS and candidate SNPs in African‐Americans and European‐Americans

    Genetic polymorphism and prostate cancer aggressiveness: A case‐only study of 1,536 GWAS and candidate SNPs in African‐Americans and European‐Americans by Jeannette T. Bensen, Zongli Xu, Gary J. Smith, James L. Mohler, Elizabeth T. H. Fontham, Jack A. Taylor

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment

    Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment by Satish J. Sharma, James L. Mohler, Supriya D. Mahajan, Stanley A. Schwartz, Liana Bruggemann, Ravikumar Aalinkeel

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer

    Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer by Mark Titus, Christopher W. Gregory, O. Harris Ford, Michael J. Schell, Susan J. Maygarden, James L. Mohler

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    5α‐reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression

    5α‐reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression by Alejandro Godoy, Elzbieta Kawinski, Yun Li, Daizo Oka, Borislav A. Alexiev, Faris Azzouni, Mark Titus, James L. Mohler

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer

    Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer by James L. Mohler, Mark Titus, Suxia Bai, Brian J. Kennerley, Fred B. Lih, Kenneth B. Tomer, Elizabeth Wilson

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    High intratumoral CD8<sup>+</sup> T‐cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy

    High intratumoral CD8<sup>+</sup> T‐cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy by Yuanquan Yang, Kristopher Attwood, Wiam Bshara, James L. Mohler, Khurshid A. Guru, Bo Xu, Paweł Kaliński, Gurkamal Chatta

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects

    Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects by Merle H. Mishel, Michael Belyea, Barbara B. Germino, Janet L. Stewart, Donald E. Bailey, Cary N. Robertson, James L. Mohler

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene<i><i>MAGEA11</i></i>

    DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene<i><i>MAGEA11</i></i> by Smitha R. James, Carlos D. Cedeno, Ashok Sharma, Wa Zhang, James L. Mohler, Kunle Odunsi, Elizabeth M. Wilson, Adam R. Karpf

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation

    Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation by Nupam P. Mahajan, Yuanbo Liu, Samarpan Majumder, Maria R. Warren, Carol E. Parker, James L. Mohler, H. Shelton Earp, Young E. Whang

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina Health Access and Prostate Cancer Treatment Project (HCaP‐NC)

    Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina Health Access and Prostate Cancer Treatment Project (HC... by Bonny Morris, Laura Farnan, Lixin Song, Elizabeth L. Addington, Ronald C. Chen, Matthew E. Nielsen, Merle H. Mishel, James L. Mohler, Jeannette T. Bensen

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Associations between patient–provider communication and socio-cultural factors in prostate cancer patients: A cross-sectional evaluation of racial differences

    Associations between patient–provider communication and socio-cultural factors in prostate cancer patients: A cross-sectional evaluation of racial differences by Lixin Song, Mark A. Weaver, Ronald C. Chen, Jeannette T. Bensen, Elizabeth T. H. Fontham, James L. Mohler, Merle H. Mishel, Paul A. Godley, Betsy Sleath

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: